A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light on how the immune system interacts with cancerous plasma cells. It could also help ...

Liam Robertson, Moorhead, is a 6 year old who developed pneumonia and enlarged lymph nodes in his neck, which required surgery. Further testing resulted in a diagnosis of Chronic Granulomatous Disease ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

Our body’s “blood factory” consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this ...

Take a look back at half a century of leading-edge research and compassionate care. More than 50 years ago when Chris Lundy was 21, he had a bone marrow transplant at Fred Hutch Cancer Center that ...

The first detailed molecular map of human bone marrow, created by WEHI researchers using state-of-the-art spatial technology, with each colour representing a different cell type. Researchers from WEHI ...

In a recently published study, researchers at Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts ...

Patients initially diagnosed with polymyalgia rheumatica (PMR) but later reclassified as having spondyloarthritis (SpA) showed bone marrow edema of the spine and sacroiliac joints on MRI. They also ...

From vampire legends to lab-grown tissue, the idea that young blood can reverse aging is no longer pure myth. A new study shows that proteins secreted by bone marrow cells, triggered by young blood, ...

Here’s what to know about symptoms and treatment of the infection. By Simar Bajaj Every summer and into fall, hand, foot and mouth disease makes the rounds in schools, playgrounds and day cares. But ...

Ingelheim, Germany, July 7, 2025 – Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI ...